OPEN END TURBO OPTIONSSCHEIN LONG - ELI LILLY & CO | Real-time BOERSE MUENCHEN 04:25:22 2024-07-11 am EDT | ||
| 64.41 EUR | +0.19% |
|
| Current month | +2.88% | ||
| 1 month | +12.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 64.41 | +0.19% |
| 24-07-10 | 64.29 | +1.47% |
| 24-07-09 | 63.36 | +1.70% |
| 24-07-08 | 62.3 | +0.55% |
| 24-07-05 | 61.96 | +1.97% |
Real-time BOERSE MUENCHEN
Last update July 11, 2024 at 04:25 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | Goldman Sachs |
| WKN | GH753H |
| ISIN | DE000GH753H5 |
| Date issued | 2021-06-09 |
| Strike | 244.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 64.7 € |
|---|---|
| Lowest since issue | 1.28 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
939.8
USD
Average target price
874.8
USD
Spread / Average Target
-6.92%
- Stock Market
- Certificates
- Certificat
